BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan · Delayed Price · Currency is JPY 50.00
-1.00 (-1.96%)
Aug 6, 2026, 1:07 PM JST
TYO:4594 Market Cap
TYO:4594 has a market cap or net worth of 7.08 billion as of August 5, 2026. Its market cap has increased by 7.23% in one year.
Market Cap
7.08B
Enterprise Value
4.93B
Revenue
84.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
50.00
ChartMarket Cap Chart
Since October 22, 2015, TYO:4594's market cap has decreased from 13.23B to 7.08B, a decrease of -46.47%. That is a compound annual growth rate of -5.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 7.08B | 32.48% |
| Dec 30, 2025 | 5.35B | 37.06% |
| Dec 30, 2024 | 3.90B | -28.70% |
| Dec 29, 2023 | 5.47B | -13.00% |
| Dec 30, 2022 | 6.29B | 7.22% |
| Dec 30, 2021 | 5.87B | -35.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 7.76B |
| StemCell Institute | 7.43B |
| Kidswell Bio | 7.25B |
| ADR Biomedical Holdings | 7.06B |
| MEDINET | 7.04B |
| CellSource | 6.39B |
| Carna Biosciences | 6.25B |
| Chordia Therapeutics | 6.03B |